Regulation of stem cell-based products
van Tigerstrom, Barbara
Health Law Journal 2007; 15: 175-220
Showing items related by title, author, creator and subject.
Fink, Donald W., Jr. (2009-06-26)Cell self-renewal and the capacity to differentiate into multiple cell types (pluripotency) are biological attributes casting stem cells as attractive candidates for development of therapies targeting indications that ...
Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Hyun, Insoo (2010-06)This paper discusses exceptional circumstances under which patients outside of clinical trials are likely to receive innovative stem cell-based interventions. These circumstances involve: (1) stem cell interventions not ...
Chester, Ronald; Sackstein, Robert (2010)The breakneck speed of scientific developments in embryonic stem (ES) cell technologies is, commensurately, ushering forth new bioethical debate(s) regarding these cells. A framework of bioethical principles is presented ...